-+ 0.00%
-+ 0.00%
-+ 0.00%

Abbott Narrows 2026 Adjusted Diluted EPS Guidance to $5.50-$5.55

PUBT·10/21/2026 12:10:27
Listen to the news
Abbott Narrows 2026 Adjusted Diluted EPS Guidance to $5.50-$5.55
  • Abbott tightened its full-year 2026 adjusted diluted EPS guidance to $5.50-$5.55, reaffirming the midpoint.
  • Full-year comparable sales growth is expected at approximately 6%.
  • Third-quarter worldwide sales reached $13 billion, up 7% on a comparable basis.
  • Adjusted diluted EPS rose 9.2% to $1.42 in the quarter.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abbott Laboratories published the original content used to generate this news brief on October 20, 2026, and is solely responsible for the information contained therein.